[Federal Register Volume 64, Number 188 (Wednesday, September 29, 1999)]
[Notices]
[Page 52511]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-25328]
[[Page 52511]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Sickle Cell Disease Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Sickle Cell Disease Advisory Committee.
Date: November 15, 1999.
Time: 9:00 am to 5:00 pm.
Agenda: Discussinoof program policies and issues.
Place: National Institutes of Health, Two Rockledge Center,
Conference Room 9104, 6701 Rockledge Drive, Bethesda, MD 20892.
Contact Person: Charles L. Peterson, MD, Director, Blood
Diseases Program, Division of Blood Diseases and Resources, National
Heart, Lung, and Blood Institute, NIH, Two Rockledge Center, Room
10158, MSC 7950, 6701 Rockledge Drive, Bethesda, MD 20892, 301/435-
0050.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: September 22, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 99-25328 Filed 9-28-99; 8:45 am]
BILLING CODE 4140-01-M
